Computational Biology Market

Market Insights

Computational biology is an interdisciplinary science that has been persistently advancing through the previous decades by using the power of mathematics and computation. The primary goal of computational biology is to use large-scale computational methods in cellular, structural, and molecular biology to answer emerging biological questions that were previously intractable using traditional approaches. The foundation of computational biology lies in computer science, statistics, chemistry, biochemistry, mathematics, genomics, genetics, molecular biology, neuroscience, animation, anatomy, visualization, etc. Researchers have come up with a wide range of computational methods to study areas such as structure prediction, cell signaling, metabolic networks, protein design, and gene regulation.

Therefore, computational biology involves the use of biological data for the construction of relations and algorithms in biological systems for the analysis of biological similarities and differences. Computational biology is primarily applied in cancer research, genomics and proteomics, pharmacology, neuroscience, genomics, and modeling. The field of computational modeling comprises computer-aided biological models that aim to design algorithms for accurate visualization of simulations for examining biological complexities. Similarly, computational neuroscience applies computational biology to understanding neurological pathways and brain models. Computational biology is also used in pharmacology in the form of visual simulations for understanding drug interactions.

The increase in bioinformatics research is the prime factor driving the growth of the computational biology market. Its widening application in genomics, drug development programs, drug designing, and other lucrative areas is anticipated to reduce the lead time to drug commercialization and, therefore, reduce the average cost as against conventional methods. Such grounds are therefore anticipated to drive stable growth of the computational biology market during the forecast period from 2018 to 2026.

Market Synopsis

Disease Modeling and Drug Discovery: Leading the Applications Worldwide

Based on the application areas, the global computational biology market is segmented into cellular and biological simulation, disease modeling and drug discovery, preclinical drug development, clinical trials, and human body simulation. As the lead time and average costs for commercializing any drug have been continuously increasing to reach the billion mark in the last few decades, there is a dire need for devising new methods to speed up the process while containing the costs. Along with this, the large-scale failure of clinical trials in the early phases of development has also led to the dominance of disease modeling and drug discovery applications in 2017. This segment’s lead is expected to last throughout the forecast period.

Future Market Size Will Be Determined by Software and Databases

Hardware, software, and services, as well as databases, are the tools that together make practical computational biology. Computational biology is mainly composed of algorithms and logic created through biological data computation and databases comprising genomic data; hardware processor units for computation also form an integral part of this field.

As the major applications of computational biology proliferate in other life-science industries, the demand for these tools will correspondingly proliferate. Software, services, and databases are the key segments that occupy the largest revenue share in the global computational biology market. The constant need for periodic updating of software and databases and the significantly high costs of these items contribute to the dominance of these segments.

current restrictions on in-house affordability to facilitate the demand for contract services

Based on service type, the computational biology market is segmented into in-house and contract services. Outsourcing to service institutions is the key trend observed in this market. Computational biology requires high-processing and sophisticated computing technologies, which cannot be a core competency of every pharmaceutical or life-sciences company. Furthermore, outside of major pharma giants, the affordability of these technologies may be an issue. Therefore, for several pharmaceutical and life-science players, outsourcing computational biology activities remains the only plausible resort.

The United States leads the global computational biology market due to greater awareness and a supportive business environment.

The major regions that contribute to the global computational biology market are North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa. Among these, North America is the clear leader in the global market in terms of revenue; higher quantities of investments in life-science research and development of drugs and diagnostics; and phenomenal technological advancements in biotechnology are the key contributors to the dominance of the North American market. Europe closely follows the lead of North America. The rapid adoption of novel biotechnologies, greater awareness, availability of required skill sets, and favorable affordability are the characteristic features of the European market.

Asia-Pacific is the fastest-growing regional market for computational biology. The region’s expanding contract research services industry, aided by favorable government policies and a growing pool of skilled labor, has prompted several companies to outsource their computational requirements to Asia Pacific service providers.

Periods of History and Forecast

This research report presents the analysis of each considered segment for the period from 2016 to 2026, using 2017 as the base year for estimations. Compounded annual growth rates (CAGRs) for each segment are calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The report also presents insights into the competitive landscape prevalent in the global computational biology market, along with a profile of key companies operating in the industry. Such major market players profiled in this report include Rhenovia Pharma SAS, Chemical Computing Group Inc., Compugen, Ltd., Accelrys, Insilico Biotechnology AG, Nimbus Discovery LLC, Entelos, Simulation Plus, Inc., Genedata AG, Leadscope, Inc., and Certara.

Key questions are answered in this report.

• What is the size of the global market for computational biology in 2017, and how will it fare through 2026?
• What is the status of the disease modeling and drug discovery segment, and what reasons lead to its dominance?
• How are software, services, and databases segmented? Which are the largest segments in the global market?
• How are contract research organizations challenging the position of in-house services?
• Will Asia-Pacific majorly challenge the dominance of the North American market?
• At what CAGR will emerging markets in Asia Pacific, Latin America, and the Middle East and Africa grow during the forecast period from 2016 to 2026?
• Which strategies are being employed by the market players for maintaining and augmenting market share?

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Market Segmentation
1.3. Research Scope
1.4. Research Methodology
1.4.1. Phase I – Secondary Research
1.4.2. Phase II – Primary Research
1.4.3. Phase III – Expert Panel Review
1.4.4. Assumptions
1.5. Market Segmentation

Chapter 2. Executive Summary
2.1. Global CB Market Portraiture
2.2. Global CB Market, by Application, 2017 (US$ Mn)
2.3. Global CB Market, by Component, 2017 (US$ Mn)
2.4. Global CB Market, by Service Type, 2017 (US$ Mn)
2.5. Global CB Market, by End User, 2017 (US$ Mn)
2.6. Global CB Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Computational Biology (CB) Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global CB Market, by Key Players, 2017

Chapter 4. Global Computational Biology (CB) Market, by Application, 2016-2026 (US$ Mn)
4.1. Overview
4.2. Cellular and Biological Simulation
4.2.1. Computational Genomics
4.2.2. Computational Proteomics
4.2.3. Pharmacogenomics
4.2.4. Transcriptomics/Metabolomics
4.3. Disease Modelling and Drug Discovery
4.3.1. Target Identification
4.3.2. Target Validation
4.3.3. Lead Discovery
4.3.4. Lead Optimization
4.4. Preclinical Drug Development
4.4.1. Pharmacokinetics
4.4.2. Pharmacodynamics
4.5. Clinical Trials
4.6. Human Body Simulation

Chapter 5. Global Computational Biology (CB) Market, by Component, 2016-2026 (US$ Mn)
5.1. Overview
5.2. Hardware
5.3. Software & Services
5.4. Databases

Chapter 6. Global Computational Biology (CB) Market, by Service Type, 2016-2026 (US$ Mn)
6.1. Overview
6.2. In-house
6.3. Contract Services

Chapter 7. Global Computational Biology (CB) Market, by End User, 2016-2026 (US$ Mn)
7.1. Overview
7.2. Industrial Applications
7.3. Research and Academia

Chapter 8. Global Computational Biology (CB) Market, by Geography, 2016 – 2026 (US$ Mn)
8.1. Overview
8.1.1. North America CB Market, 2016-2026 (US$ Mn)
8.1.2. North America CB Market, by Application, 2016 – 2026 (US$ Mn)
8.1.3. North America CB Market, by Component, 2016 – 2026 (US$ Mn)
8.1.4. North America CB Market, by Service Type, 2016 – 2026 (US$ Mn)
8.1.5. North America CB Market, by End User, 2016 – 2026 (US$ Mn)
8.1.6. North America CB Market, by Country, 2016 – 2026 (US$ Mn)
8.1.6.1. U.S.
8.1.6.2. Canada
8.2. Europe CB Market, 2016 – 2026 (US$ Mn)
8.2.1. Europe CB Market, by Application, 2016 – 2026 (US$ Mn)
8.2.2. Europe CB Market, by Component, 2016 – 2026 (US$ Mn)
8.2.3. Europe CB Market, by Service Type, 2016 – 2026 (US$ Mn)
8.2.4. Europe CB Market, by End User, 2016 – 2026 (US$ Mn)
8.2.5. Europe CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.2.5.1. U.K.
8.2.5.2. Germany
8.2.5.3. Rest of Europe
8.3. Asia Pacific CB Market, 2016 – 2026 (US$ Mn)
8.3.1. Asia Pacific CB Market, by Application, 2016 – 2026 (US$ Mn)
8.3.2. Asia Pacific CB Market, by Component, 2016 – 2026 (US$ Mn)
8.3.3. Asia Pacific CB Market, by Service Type, 2016 – 2026 (US$ Mn)
8.3.4. Asia Pacific CB Market, by End User, 2016 – 2026 (US$ Mn)
8.3.5. Asia Pacific CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.3.5.1. China
8.3.5.2. Japan
8.3.5.3. Rest of Asia Pacific
8.4. Latin America CB Market, 2016 – 2026 (US$ Mn)
8.4.1. Latin America CB Market, by Application, 2016 – 2026 (US$ Mn)
8.4.2. Latin America CB Market, by Component, 2016 – 2026 (US$ Mn)
8.4.3. Latin America CB Market, by Service Type, 2016 – 2026 (US$ Mn)
8.4.4. Latin America CB Market, by End User, 2016 – 2026 (US$ Mn)
8.4.5. Latin America CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
8.4.5.1. Brazil
8.4.5.2. Mexico
8.4.5.3. Rest of Latin America
8.5. Middle East & Africa CB Market, 2016 – 2026 (US$ Mn)
8.5.1. Middle East & Africa CB Market, by Application, 2016 – 2026 (US$ Mn)
8.5.2. Middle East & Africa CB Market, by Component, 2016 – 2026 (US$ Mn)
8.5.3. Middle East & Africa CB Market, by Service Type, 2016 – 2026 (US$ Mn)
8.5.4. Middle East & Africa CB Market, by End User, 2016 – 2026 (US$ Mn)
8.5.5. Middle East & Africa CB Market, by Region, 2016 – 2026 (US$ Mn)
8.5.5.1. GCC
8.5.5.2. Rest of Middle East & Africa

Chapter 9. Company Profiles
9.1. Rhenovia Pharma SAS
9.1.1. Business Description
9.1.2. Financial Information (Subject to Data Availability)
9.1.3. Product Portfolio
9.1.4. Key Developments
9.2. Chemical Computing Group Inc.
9.3. Compugen, Ltd
9.4. Accelrys
9.5. Insilico Biotechnology AG
9.6. Nimbus Discovery LLC
9.7. Entelos
9.8. Simulation Plus, Inc.
9.9. Genedata AG
9.10. Leadscope, Inc
9.11. Certara

List of Figures

FIG 1. Computational Biology (CB) Market: Research Methodology
FIG 2. CB Market Segmentation
FIG 3. Global CB Market, by Application, 2017 (US$ Mn)
FIG 4. Global CB Market, by Component, 2017 (US$ Mn)
FIG 5. Global CB Market, by Service Type, 2017 (US$ Mn)
FIG 6. Global CB Market, by End User, 2017 (US$ Mn)
FIG 7. Global CB Market, by Geography, 2017 (US$ Mn)
FIG 8. Attractive Investment Proposition, by Geography, 2017
FIG 9. Competitive Analysis: Global CB Market, by Key Players, 2017
FIG 10. Global Computational Genomics Market, 2016-2026(US$ Mn)
FIG 11. Global Computational Proteomics Market, 2016-2026 (US$ Mn)
FIG 12. Global CB Market for Pharmacogenomics, 2016-2026 (US$ Mn)
FIG 13. Global CB Market for Transcriptomics/Metabolomics, 2016-2026 (US$ Mn)
FIG 14. Global CB Market for Target Identification, 2016-2026 (US$ Mn)
FIG 15. Global CB Market for Target Validation, 2016-2026 (US$ Mn)
FIG 16. Global CB Market for Lead Discovery, 2016-2026 (US$ Mn)
FIG 17. Global CB Market for Lead Optimization, 2016-2026 (US$ Mn)
FIG 18. Global CB Market for Pharmacokinetics, 2016-2026 (US$ Mn)
FIG 19. Global CB Market for Pharmacodynamics, 2016-2026 (US$ Mn)
FIG 20. Global CB Market for Clinical Trials, 2016-2026 (US$ Mn)
FIG 21. Global CB Market for Human Body Simulation, 2016-2026 (US$ Mn)
FIG 22. Global Computational Biology Hardware Market, 2016-2026 (US$ Mn)
FIG 23. Global Computational Biology Software & Services Market, 2016-2026 (US$ Mn)
FIG 24. Global Computational Biology Databases Market, 2016-2026 (US$ Mn)
FIG 25. Global In-house CB Market, 2016-2026 (US$ Mn)
FIG 26. Global Contract Services CB Market , 2016-2026 (US$ Mn)
FIG 27. Global CB Market for Industrial Applications, 2016-2026 (US$ Mn)
FIG 28. Global CB Market for Research and Academia, 2016-2026 (US$ Mn)
FIG 29. U.S. CB Market, 2016-2026 (US$ Mn)
FIG 30. Canada CB Market, 2016-2026 (US$ Mn)
FIG 31. U.K. CB Market, 2016-2026 (US$ Mn)
FIG 32. Germany CB Market, 2016-2026 (US$ Mn)
FIG 33. Rest of Europe CB Market, 2016-2026 (US$ Mn)
FIG 34. China CB Market, 2016-2026 (US$ Mn)
FIG 35. Japan CB Market, 2016-2026 (US$ Mn)
FIG 36. Rest of Asia Pacific CB Market, 2016-2026 (US$ Mn)
FIG 37. Brazil CB Market, 2016-2026 (US$ Mn)
FIG 38. Mexico CB Market, 2016-2026 (US$ Mn)
FIG 39. Rest of Latin America CB Market, 2016-2026 (US$ Mn)
FIG 40. GCC CB Market, 2016-2026 (US$ Mn)
FIG 41. Rest of Middle East and Africa CB Market, 2016-2026 (US$ Mn)

List of Tables

TABLE 1 Global Computational Biology (CB) Market Portraiture
TABLE 2 Global CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 3 Global CB Market for Cellular and Biological Simulation, by Type, 2016 – 2026 (US$ Mn)
TABLE 4 Global CB Market for Disease Modelling and Drug Discovery, by Type, 2016 – 2026 (US$ Mn)
TABLE 5 Global CB Market for Preclinical Drug Development, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 Global CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 7 Global CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 8 Global CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 9 Global CB Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 10 North America CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 11 North America CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 12 North America CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 13 North America CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 14 North America CB Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 15 Europe CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 16 Europe CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 17 Europe CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 18 Europe CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 19 Europe CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 Asia Pacific CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 21 Asia Pacific CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 22 Asia Pacific CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 23 Asia Pacific CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 24 Asia Pacific CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 25 Latin America CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 26 Latin America CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 27 Latin America CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 28 Latin America CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 29 Latin America CB Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 30 Middle East and Africa CB Market, by Application, 2016 – 2026 (US$ Mn)
TABLE 31 Middle East and Africa CB Market, by Component, 2016 – 2026 (US$ Mn)
TABLE 32 Middle East and Africa CB Market, by Service Type, 2016 – 2026 (US$ Mn)
TABLE 33 Middle East and Africa CB Market, by End User, 2016 – 2026 (US$ Mn)
TABLE 34 Middle East and Africa CB Market, by Region, 2016 – 2026 (US$ Mn)
TABLE 35 Rhenovia Pharma SAS: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 36 Chemical Computing Group Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 37 Compugen, Ltd: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 38 Accelrys: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 39 Insilico Biotechnology AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 40 Nimbus Discovery LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 41 Entelos: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 42 Simulation Plus, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 43 Genedata AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 44 Leadscope, Inc.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 45 Certara: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)